Logo image of JKS

JINKOSOLAR HOLDING CO-ADR (JKS) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:JKS - US47759T1007 - ADR

27.12 USD
+0.29 (+1.08%)
Last: 1/9/2026, 8:04:00 PM
27.12 USD
0 (0%)
After Hours: 1/9/2026, 8:04:00 PM
Fundamental Rating

3

Taking everything into account, JKS scores 3 out of 10 in our fundamental rating. JKS was compared to 113 industry peers in the Semiconductors & Semiconductor Equipment industry. JKS may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, JKS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

JKS had negative earnings in the past year.
JKS had positive earnings in each of the past 5 years.
Of the past 5 years JKS 4 years had a positive operating cash flow.
JKS Yearly Net Income VS EBIT VS OCF VS FCFJKS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B

1.2 Ratios

JKS has a Return On Assets of -1.53%. This is comparable to the rest of the industry: JKS outperforms 43.36% of its industry peers.
JKS's Return On Equity of -10.18% is on the low side compared to the rest of the industry. JKS is outperformed by 68.14% of its industry peers.
Industry RankSector Rank
ROA -1.53%
ROE -10.18%
ROIC N/A
ROA(3y)1.06%
ROA(5y)0.92%
ROE(3y)7.15%
ROE(5y)6.05%
ROIC(3y)N/A
ROIC(5y)N/A
JKS Yearly ROA, ROE, ROICJKS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

JKS's Profit Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 8.39%, JKS is doing worse than 87.61% of the companies in the same industry.
In the last couple of years the Gross Margin of JKS has declined.
The Profit Margin and Operating Margin are not available for JKS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-67.68%
PM growth 5Y-54.4%
GM growth 3Y-12.56%
GM growth 5Y-9.8%
JKS Yearly Profit, Operating, Gross MarginsJKS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1

2. Health

2.1 Basic Checks

JKS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, JKS has less shares outstanding
Compared to 5 years ago, JKS has more shares outstanding
The debt/assets ratio for JKS is higher compared to a year ago.
JKS Yearly Shares OutstandingJKS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
JKS Yearly Total Debt VS Total AssetsJKS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

JKS has a Debt/Equity ratio of 1.80. This is a high value indicating a heavy dependency on external financing.
JKS's Debt to Equity ratio of 1.80 is on the low side compared to the rest of the industry. JKS is outperformed by 91.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC2.45%
JKS Yearly LT Debt VS Equity VS FCFJKS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B

2.3 Liquidity

A Current Ratio of 1.33 indicates that JKS should not have too much problems paying its short term obligations.
JKS has a worse Current ratio (1.33) than 85.84% of its industry peers.
A Quick Ratio of 1.07 indicates that JKS should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.07, JKS is doing worse than 84.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.07
JKS Yearly Current Assets VS Current LiabilitesJKS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

5

3. Growth

3.1 Past

JKS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -251.26%.
The Earnings Per Share has been decreasing by -2.87% on average over the past years.
JKS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.26%.
Measured over the past years, JKS shows a very strong growth in Revenue. The Revenue has been growing by 25.40% on average per year.
EPS 1Y (TTM)-251.26%
EPS 3Y13.84%
EPS 5Y-2.87%
EPS Q2Q%-1159.57%
Revenue 1Y (TTM)-22.26%
Revenue growth 3Y31.23%
Revenue growth 5Y25.4%
Sales Q2Q%-35.01%

3.2 Future

The Earnings Per Share is expected to grow by 23.29% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 3.81% on average over the next years.
EPS Next Y-305.28%
EPS Next 2Y-21.12%
EPS Next 3Y23.29%
EPS Next 5YN/A
Revenue Next Year-25.69%
Revenue Next 2Y-1.42%
Revenue Next 3Y3.81%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
JKS Yearly Revenue VS EstimatesJKS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B 80B 100B
JKS Yearly EPS VS EstimatesJKS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 -5 10

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JKS. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 16.32 indicates a correct valuation of JKS.
Based on the Price/Forward Earnings ratio, JKS is valued cheaply inside the industry as 91.15% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.88. JKS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 16.32
JKS Price Earnings VS Forward Price EarningsJKS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of JKS indicates a somewhat cheap valuation: JKS is cheaper than 78.76% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.9
JKS Per share dataJKS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200

4.3 Compensation for Growth

A more expensive valuation may be justified as JKS's earnings are expected to grow with 23.29% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-21.12%
EPS Next 3Y23.29%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.96%, JKS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.57, JKS pays a better dividend. On top of this JKS pays more dividend than 98.23% of the companies listed in the same industry.
JKS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.94.
Industry RankSector Rank
Dividend Yield 4.96%

5.2 History

JKS has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
JKS Yearly Dividends per shareJKS Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

DPN/A
EPS Next 2Y-21.12%
EPS Next 3Y23.29%
JKS Yearly Income VS Free CF VS DividendJKS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B

JINKOSOLAR HOLDING CO-ADR

NYSE:JKS (1/9/2026, 8:04:00 PM)

After market: 27.12 0 (0%)

27.12

+0.29 (+1.08%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-17 2025-11-17/bmo
Earnings (Next)N/A N/A
Inst Owners12.76%
Inst Owner Change0%
Ins Owners2%
Ins Owner ChangeN/A
Market Cap1.40B
Revenue(TTM)92.26B
Net Income(TTM)-1.87B
Analysts50.77
Price Target27.42 (1.11%)
Short Float %23.59%
Short Ratio3.55
Dividend
Industry RankSector Rank
Dividend Yield 4.96%
Yearly Dividend1.5
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)146.1%
Min EPS beat(2)-49.23%
Max EPS beat(2)341.42%
EPS beat(4)3
Avg EPS beat(4)228.1%
Min EPS beat(4)-49.23%
Max EPS beat(4)488.11%
EPS beat(8)6
Avg EPS beat(8)159.23%
EPS beat(12)8
Avg EPS beat(12)116.31%
EPS beat(16)10
Avg EPS beat(16)129.53%
Revenue beat(2)0
Avg Revenue beat(2)-86.62%
Min Revenue beat(2)-87.59%
Max Revenue beat(2)-85.65%
Revenue beat(4)0
Avg Revenue beat(4)-86.44%
Min Revenue beat(4)-88%
Max Revenue beat(4)-84.52%
Revenue beat(8)0
Avg Revenue beat(8)-85.83%
Revenue beat(12)3
Avg Revenue beat(12)-53.57%
Revenue beat(16)4
Avg Revenue beat(16)-41.02%
PT rev (1m)8.66%
PT rev (3m)10.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)20.89%
EPS NY rev (3m)14.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)1.02%
Revenue NY rev (3m)-1.73%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 16.32
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B 0.53
P/tB 0.61
EV/EBITDA 16.9
EPS(TTM)-4.33
EYN/A
EPS(NY)1.66
Fwd EY6.13%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS230.31
BVpS51.03
TBVpS44.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.53%
ROE -10.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.39%
FCFM N/A
ROA(3y)1.06%
ROA(5y)0.92%
ROE(3y)7.15%
ROE(5y)6.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-67.68%
PM growth 5Y-54.4%
GM growth 3Y-12.56%
GM growth 5Y-9.8%
F-ScoreN/A
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF N/A
Debt/EBITDA 10.8
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 1.07
Altman-Z N/A
F-ScoreN/A
WACC2.45%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-251.26%
EPS 3Y13.84%
EPS 5Y-2.87%
EPS Q2Q%-1159.57%
EPS Next Y-305.28%
EPS Next 2Y-21.12%
EPS Next 3Y23.29%
EPS Next 5YN/A
Revenue 1Y (TTM)-22.26%
Revenue growth 3Y31.23%
Revenue growth 5Y25.4%
Sales Q2Q%-35.01%
Revenue Next Year-25.69%
Revenue Next 2Y-1.42%
Revenue Next 3Y3.81%
Revenue Next 5YN/A
EBIT growth 1Y-189.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year173.76%
EBIT Next 3Y119.1%
EBIT Next 5YN/A
FCF growth 1Y-45.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.87%
OCF growth 3Y239.49%
OCF growth 5Y64.22%

JINKOSOLAR HOLDING CO-ADR / JKS FAQ

What is the ChartMill fundamental rating of JINKOSOLAR HOLDING CO-ADR (JKS) stock?

ChartMill assigns a fundamental rating of 3 / 10 to JKS.


What is the valuation status of JINKOSOLAR HOLDING CO-ADR (JKS) stock?

ChartMill assigns a valuation rating of 3 / 10 to JINKOSOLAR HOLDING CO-ADR (JKS). This can be considered as Overvalued.


What is the profitability of JKS stock?

JINKOSOLAR HOLDING CO-ADR (JKS) has a profitability rating of 2 / 10.


How financially healthy is JINKOSOLAR HOLDING CO-ADR?

The financial health rating of JINKOSOLAR HOLDING CO-ADR (JKS) is 1 / 10.


What is the earnings growth outlook for JINKOSOLAR HOLDING CO-ADR?

The Earnings per Share (EPS) of JINKOSOLAR HOLDING CO-ADR (JKS) is expected to decline by -305.28% in the next year.